key: cord-1028686-x011i6x6 authors: Kara, Murat; Ekiz, Timur; Ricci, Vincenzo; Kara, Özgür; Chang, Ke-Vin; Özçakar, Levent title: ‘Scientific Strabismus’ or two related pandemics: coronavirus disease and vitamin D deficiency date: 2020-05-12 journal: The British journal of nutrition DOI: 10.1017/s0007114520001749 sha: 562138dc8e515afe79f830ff3a7a1906439bcded doc_id: 1028686 cord_uid: x011i6x6 [Figure: see text] On 11 March 2020, the WHO announced the novel coronavirus disease outbreak to be a global pandemic (1) . The spread of COVID-19 is becoming unstoppable, and as of 15 May, more than 4 500 000 people have been infected and more than 300 000 people have died ( Fig. 1) (1) . The severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) is the pathogen of COVID-19. SARS-CoV-2, classified into two β coronaviruses, is an enveloped, positive-sense and single-stranded RNA virus of about 30 kb. The life cycle of the virus with the host comprises mainly five steps as follows: attachment, penetration, biosynthesis, maturation and release. Once SARS-CoV-2 attaches to the host receptors, it penetrates the cells via endocytosis/membrane fusion. Herein, angiotensin-converting enzyme 2 is the entry and functional receptor of SARS-CoV-2. It has been shown that the spike for SARS-CoV-2, structural membrane proteins formed by the trans-membrane trimetric glycoprotein protruding from the viral surface, also binds to angiotensin-converting enzyme 2. After the viral contents are released inside the host cells, viral RNA enters the nucleus to replicate. As for the biosynthesis, viral mRNA is used to make viral proteins. The new viral particles are formed in the maturation step and then released (2) . Angiotensin-converting enzyme 2 plays an important role for the interaction between the classical and non-classical pathway of the renin angiotensin system. The former acts through the angiotensin II type 1 receptors, and its increased activity leads to fibrosis, inflammation and angiogenesis. The latter acts through the Mas receptors and has opposing effects to the angiotensin II type 1 receptors (3) . Angiotensin-converting enzyme 2 is expressed by the epithelial cells of lungs, intestines, kidneys and blood vessels; therefore, the aforementioned tissues/organs are vulnerable to SARS-CoV-2 infection (4) . Additionally, activation of the renin angiotensin system is significantly associated with increased morbidity and mortality as in hypertension (3) . On the other hand, vitamin D deficiency has also been described as pandemic and a global public health problem, especially in Europe (Table 1) . Regardless of age, ethnicity and latitude, recent data showed that 40 % of Europeans are vitamin D deficient (25-hydroxyvitamin D (25(OH)D) levels <50 nmol/l), and 13 % are severely deficient (25(OH)D < 30 nmol/l) (44) . According to regression analyses, a quadratic relationship was found between the prevalences of vitamin D deficiency in most commonly affected countries by COVID-19 and the latitudes (Fig. 2) . Interestingly, vitamin D deficiency is more common in the subtropical and mid-latitude countries than the tropical and high-latitude countries. Contrary to the expectation, the most commonly affected countries with severe vitamin D deficiency are from the subtropical (Saudi Arabia 46 %; Qatar 46 %; Iran 33·4 %; Chile 26·4 %) and mid-latitude (France 27·3 %; Portugal 21·2 %; Austria 19·3 %) regions. On the other hand, severe vitamin D deficiency was found to be nearly 0 % in some high-latitude countries (e.g. Norway, Finland, Sweden, Denmark and Netherlands). The low prevalences of severe vitamin D deficiencies in high-latitude countries (except for the UK; 23·7 %) can possibly be attributed to the high awareness of vitamin D deficiency, high amount of vitamin D supplementation, food fortification and health policies as well (44) . Indeed, as the main source of vitamin D is exposure of the skin to sun (UV-B), it has long been supposed that living in a sunny country guarantees sufficient vitamin D levels. However, there is increasing evidence that vitamin D deficiency may have been underestimated/ignored in low latitude, even in tropical countries (45) . The risks for vitamin D deficiency encompass obesity, elderly, lack of proper sun (UV-B) exposure, dark skin, smoking, living with air pollution and the presence of co-morbid diseases such as infection, cancer, CVD, chronic respiratory disease, osteoporosis, sarcopenia and diabetes mellitus (46, 47) . Further, it is known that severe vitamin D deficiency dramatically increases the risk of mortality, infections and many other diseases. As such, it should indisputably be prevented whenever detected/ possible (46) . Vitamin D hormone has important functionsincluding immunomodulant, anti-inflammatory and anti-infective roles (47) . It acts via monocyte and cell-mediated immunity stimulation, suppression of lymphocyte proliferation, antibody production and cytokine synthesis (48) . Human lung cells are able to intracellularly convert the inactive 25(OH)D to its active form 1,25(OH)D which reduces proinflammatory cytokines and increases peptides (e.g. the innate antimicrobial peptide cathelicidin) (48) . Cathelicidin has direct antiviral activity against enveloped respiratory viruses such as hepatitis B, influenza, respiratory syncytial virus and possibly the COVID-19 as well (48) . Other than the above-mentioned functions, vitamin D has also anti-fibrotic effects. The renin-inhibiting activity and down-regulation of the renin angiotensin system activity seem to be the beneficial effects of vitamin D. Moreover, vitamin D has been shown to suppress angiotensinogen and regulate its expression (49) . The distribution of community outbreaks shows seasonal patterns along certain latitude, temperature and humidity, that is, similar to the behaviour of seasonal viral respiratory tract infections. It has been reported that COVID-19 displays significant spread in mid-latitude (35-50°N 0 ) regions and/or in those with an average temperature of 5-11°C and low humidity ( Fig. 1) (1, 50) . Coronaviruses are very stable at 4°C (viable for up to 3 d) and can survive at −20°C (for up to 2 years) (1) . Depending on some parameters (e.g. temperature, humidity and sunlight), they can live on different surfaces for a few days. They are thermolabile; decreased sunlight, low temperatures and less humidity seem to be favourable for COVID-19 (1) . Although natural UV (UV-C) from the sunlight may not be strong enough to kill COVID-19, its antimicrobial efficacy has long been shown to inactivate, thus preventing the transmission of airborne-mediated infections such as influenza and tuberculosis (51) . Further, UV-B from the sun can induce endogenous synthesis of vitamin D in the skinbeing the main source of vitamin D other than the dietary intake or supplementation. These factors might possibly be explanatory as regards the low prevalence of COVID-19 in subtropical and southern countries. Patients infected with COVID-19 have higher mortality rates if they are older, that is, 8·0 % (70-79 years) and 14·8 % (>80 years). The similar rates for co-morbid conditions are as 10·5 % (CVD), 7·3 % (diabetes mellitus), 6·3 % (chronic Coronavirus disease and vitamin D deficiency 3 respiratory disease), 6·0 % (hypertension) and 5·6 % (cancer) (52) . Older adults with any of these co-morbid diseases are at high risk for COVID-19 infectionespecially in the presence of severe vitamin D deficiency (53) . To this end, since there is positive/ strong evidence concerning the effects of vitamin D against viral respiratory infections, it would not be unsound to say that vitamin D supplementation may decrease viral induction and inflammatory genes, and incidence/severity of respiratory tract infections (48) . In this sense, a meta-analysis of twenty-five randomised controlled trials showed that vitamin D supplementation has a preventive effect against acute respiratory tract infections and that the benefit is higher in those subjects receiving daily or weekly vitamin D without additional bolus doses, and in those having severe vitamin D deficiency at baseline (54) . Although vitamin D was primarily recognised for bone metabolism, increasing evidence indicates its proper function for nearly every tissue in the body including brain, heart, lung, muscle, immune system and skin (55) . Therefore, the treatment of vitamin D deficiency would be vital for several diseases including cardiovascular and neurological disorders, cancers, autoimmune diseases and infections as well (55) . Likewise, a recent review recommended that in people at risk of influenza/ COVID-19 infection, 250 μg/d of vitamin D 3 for a few weeks (or a month),that is, to rapidly increase the 25(OH)D concentrations and then 125 μg/d in the follow-up can be considered (47) . The target should be to raise its value above 40-60 ng/ml. Additionally, the authors also suggested higher vitamin D 3 doses for infected patients with COVID-19. For sure, attention should be paid not to take high calcium supplementation for potential risk of hypercalcaemia while taking high doses of vitamin D 3 . Needless to say, as vitamin D is synthesised mainly in the skin, sun (UV-B) exposure (15-20 min daily) inducing the light pink colour of minimal erythema would be the natural way of production and activation of vitamin D by keratinocytes (55) . Accordingly, presenting this paper, we would like to call attention to the possible association between severe vitamin D deficiency and mortality pertaining to COVID-19. Given its rare side effects and relatively wide safety, prophylactic vitamin D supplementation and/or food fortification might reasonably serve as a very convenient and incomparable/invaluable adjuvant therapy for these two worldwide public health problems alike. World Health Organization (2020) Coronavirus disease (COVID-2019) situation reports COVID-19 pathophysiology: a review Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19 Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection Lifestyle and 25-hydroxy-vitamin D among communitydwelling old adults with dementia, mild cognitive impairment, or normal cognitive function A predictive model of vitamin D insufficiency in older community people: from the Sao Paulo Aging & Health study (SPAH) Standardizing 25-hydroxyvitamin D values from the Canadian Health Measures Survey Association between vitamin D deficiency and insulin resistance markers in euthyroid non-diabetic individuals Vitamin D status among older adults residing in the littoral and Andes mountains in Ecuador High prevalence of hypovitaminosis D in Mexicans aged 14 years and older and its correlation with parathyroid hormone Passive commuting and higher sedentary time is associated with vitamin D deficiency in adult and older women: results from Chilean National Health Survey Low serum vitamin D is not associated with an increase in mortality in oldest old subjects: the Octabaix three-year follow-up study Serum 25-hydroxyvitamin D and incidence of diabetes in elderly people: the PRO.V.A. Study The prevalence and determinants of vitamin D status in community-dwelling older adults: results from the English Longitudinal Study of Ageing (ELSA) Vitamin D deficiency in community-dwelling elderly is not associated with age-related macular degeneration Epigenetic clock and leukocyte telomere length are associated with vitamin D status, but not with functional assessments and frailty in the Berlin Aging Study II Prevalence of vitamin D deficiency in the North-West region of Russia: a cross-sectional study Prevalence of vitamin D deficiency in otherwise healthy individuals between the ages of 18 and 90 years in southeast Turkey Vitamin D deficiency is common among adults in Wallonia (Belgium, 51°30' North): findings from the Nutrition, Environment and Cardio-Vascular Health study Determinants of vitamin D status in physically active elderly in the Netherlands Serum concentrations of 25-hydroxyvitamin D and immunoglobulins in an older Swiss cohort: results of the Senior Labor Study Prevalence of vitamin D deficiency and its predictors in the Portuguese population: a nationwide population-based study Vitamin D insufficiency over 5 years is associated with increased fracture risk-an observational cohort study of elderly women Evaluation of vitamin D standardization program protocols for standardizing serum 25-hydroxyvitamin D data: a case study of the program's potential for national nutrition and health surveys Vitamin D intake and status in Austria and its effects on some health indicators Vitamin D status in Poland Seasonal variation of serum vitamin D levels in Romania Standardizing serum 25-hydroxyvitamin D data from four Nordic population samples using the vitamin D standardization program protocols: shedding new light on vitamin D status in Nordic individuals Vitamin D deficiency in Europe: pandemic? Smoking is a significant determinant of low serum vitamin D in young and middle-aged healthy males Vitamin D status, dependence on age, and seasonal variations in the concentration of vitamin D in Croatian postmenopausal women initially screened for osteoporosis A comparison study of vitamin D deficiency among older adults in China and the United States Genetic and environmental predictors of serum 25-hydroxyvitamin D concentrations among middle-aged and elderly Chinese in Singapore Impact of demographic, environmental, and lifestyle factors on vitamin D sufficiency in 9084 Japanese adults Defining vitamin D deficiency and its relationship to hypertension in postmenopausal Korean women Vitamin D levels in an Australian population Vitamin D status in Malaysian men and its associated factors Prevalence and trends of vitamin D deficiency among Iranian adults: a longitudinal study from 2001-2013 Vitamin D status among patients visiting a tertiary care center in Riyadh, Saudi Arabia: a retrospective review of 3475 cases High prevalence of vitamin D deficiency and insufficiency in a low income peri-urban community in Karachi Serum 25(OH)D concentrations in sunny Israel Low vitamin D and cardiovascular risk factors in males and females from a sunny, rich country Vitamin D status in Kancheepuram District Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency: a position statement of the European Calcified Tissue Society Vitamin D status in the tropics: is sunlight exposure the main determinant? National estimates of serum total 25-hydroxyvitamin D and metabolite concentrations measured by liquid chromatography-tandem mass spectrometry in the US population during Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths Vitamin D and the antiviral state Biochemistry, Physiology And Diagnostics Temperature, humidity and latitude analysis to predict potential spread and seasonality for COVID-19 Far-UVC light: a new tool to control the spread of airborne-mediated microbial diseases Novel Coronavirus Pneumonia Emergency Response Epidemiology Team (2020) The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China Vitamin D supplementation could possibly improve clinical outcomes of patients infected with Coronavirus-2019 (COVID-2019 Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data Vitamin D and the skin: focus on a complex relationship: a review This research received no specific grant from any funding agency, commercial or not-for-profit sectors.M. K. performed study concept and design, acquisition of the data, writing and drafting the manuscript, and final approval and is the guarantor of the manuscript. T. E. performed study concept and design, acquisition of the data, writing and drafting the manuscript and final approval. V. R. performed study concept and design, writing and drafting the manuscript and final approval. Ö. K. performed study concept and design, writing and drafting the manuscript and final approval. K.-V. C. performed study concept and design, writing and drafting the manuscript and final approval. L. Ö. performed study concept and design, writing and drafting the manuscript, and final approval and is the supervisor.The authors report no conflicts of interest.